Glyang Tablet 10mg (Empagliflozin)

Adult dose

The recommended dosage of this medicine is 10 mg once daily for monotherapy and additional combination therapy with insulin or other glucose-lowering agents. If a 10 mg dose is well tolerated and further blood sugar control is required, the dosage may be increased to 25 mg once daily. This medicine can be taken regardless of meals. Swallow the tablet whole. If a dose is missed, take it as soon as remembered without doubling the dose.

This medicine should not be used in certain patients. For example, it should not be administered to those who have an allergy to the active ingredient of this medicine, type 1 diabetes patients, patients with severe renal impairment, and those with lactose intolerance. In patients with impaired renal function, this medicine should be used cautiously, and if renal function continues to decline, the medication should be discontinued. Furthermore, this medicine may not be effective in patients with end-stage renal disease or those undergoing dialysis. It is indicated for limited use only in patients with mild to moderate heart failure and is not recommended for patients with severe heart failure. The risk of hypoglycemia may increase when used with insulin or medications that stimulate insulin secretion, so dosage adjustments may be necessary when used in combination with these drugs. During treatment, side effects such as hypoglycemia, genital infections, urinary tract infections, increased urination, and volume depletion may occur. Special caution is advised for elderly patients over 75 years, as they are at higher risk for fluid loss. Serious metabolic abnormalities such as ketoacidosis may occur; if symptoms such as nausea, vomiting, abdominal pain, or difficulty breathing develop, consult a physician immediately. This medicine may also cause liver damage, so patients with liver function impairment should be cautious. Blood pressure decreases and symptoms of dehydration may occur during treatment, making it essential to regularly monitor blood pressure and fluid status. Caution is advisable during driving or operation of machinery due to the risk of hypoglycemia. Pregnant women or those planning to become pregnant should avoid using this medicine, and nursing mothers should also refrain from taking it. Safety and efficacy have not been established in children under 18 years, so it is not used in this population. Although specific toxicity symptoms related to overdose have not been reported, appropriate treatment is required depending on the clinical condition. This medicine should be kept out of the reach of children, and caution is advised against transferring it to other containers as this may negatively affect the quality.

Serious side effects

Hives, angioedema, ketoacidosis, urosepsis, pyelonephritis, perineal necrosis, severe allergic reactions, severe skin reactions, liver abnormalities (jaundice), acute kidney injury, pyelonephritis, stent thrombosis, deep vein thrombosis, acute cholecystitis, autoimmune hepatitis, cholelithiasis, serious neurological symptoms (e.g., stroke, intracranial aneurysm), seizures, cognitive confusion, visual disturbances, paralysis, severe edema, or urination issues.

Mild side effects

Hypoglycemia, vaginitis, vulvitis, balanitis and other genital infections, increased urination, rash, itching, dehydration, hypotension, decreased blood volume, fluid loss, headache, dizziness, drowsiness, anxiety, fatigue, fever, pain, chest pain, weakness, insomnia, cough, difficulty breathing, blurred vision, dry eyes, glaucoma, various gastrointestinal disturbances, etc., which include mild or moderate side effects.

This medicine should be stored in a tightly closed container to protect it from air and moisture. Moreover, it is advisable to keep the medicine at room temperature between 1°C and 30°C, avoiding excessively hot or cold locations.

Appearance

Light yellow, biconvex, round film-coated tablet

Package unit

30 tablets/box [(*10 tablets/PTP*3)]